circATP5SL promotes IH progression by regulating IGF1R expression through adsorption of miR-873-5p, elucidating circATP5SL as a promising therapeutic target for the prognostication and treatment of IH.
CircATP5SL promotes infantile haemangiomas progression via IGF1R regulation by targeting miR-873-5p.